Coumarin sulfonates: As potential leads for ROS inhibition

Add time:08/08/2019    Source:sciencedirect.com

Coumarin sulfonates 4–43 were synthesized by reacting 3-hydroxy coumarin 1, 4-hydroxy coumarin 2 and 6-hydroxy coumarin 3 with different substituted sulfonyl chlorides and subjected to evaluate for their in vitro immunomodulatory potential. The compounds were investigated for their effect on oxidative burst activity of zymosan stimulated whole blood phagocytes using a luminol enhanced chemiluminescence technique. Ibuprofen was used as standard drug (IC50 = 54.2 ± 9.2 μM). Eleven compounds 6 (IC50 = 46.60 ± 14.6 μM), 8 (IC50 = 11.50 ± 6.5 μM), 15 (IC50 = 21.40 ± 12.2 μM), 19 (IC50 = 5.75 ± 0.86 μM), 22 (IC50 = 10.27 ± 1.06 μM), 23 (IC50 = 33.09 ± 5.61 μM), 24 (IC50 = 4.93 ± 0.58 μM), 25 (IC50 = 21.96 ± 14.74 μM), 29 (IC50 = 12.47 ± 9.2 μM), 35 (IC50 = 20.20 ± 13.4 μM) and 37 (IC50 = 14.47 ± 5.02 μM) out of forty demonstrated their potential suppressive effect on production of reactive oxygen species (ROS) as compared to ibuprofen. All the synthetic derivatives 4–43 were characterized by different available spectroscopic techniques such as 1H NMR, 13C NMR, EIMS and HRMS. CHN analysis was also performed.

We also recommend Trading Suppliers and Manufacturers of COUMARIN-6-SULFONYL CHLORIDE (cas 10543-42-7). Pls Click Website Link as below: cas 10543-42-7 suppliers

Prev:Synthesis and spectroscopic study of 2,7-diethylamino-2-oxo-2H-chromen-3-yl benzothiazole-6-sulfonyl chlorides and its derivatives
Next:Solubilities of pharmaceutical and bioactive compounds in trihexyl(tetradecyl)phosphonium chloride ionic liquid)